Kogan.com has boasted one of the largest share price increases of 2020. What’s the story behind this rise?

The rise and fall of the buy now, pay later stock Afterpay is the talk of the town, with Zip Co also grabbing headlines. But what other BNPL providers are out there?

Antisense Therapeutics (ANP) has submitted its antisense drug for Orphan Drug Designation with the US Food and Drug Administration (FDA), and is seeking similar designation in the European market with its application to the European Medicines Agency (EMA) Committee for Orphan Medicinal Products.

The Switzer Fear, Greed and Hope Survey is a quarterly survey that has tracked how COVID-19 has changed the investing attitudes of Switzer readers surveyed in February, May and August 2020.

August 28 is Equal Pay Day in Australia. This date is said to mark the number of extra days the average woman must work to earn the same wage as a man for the previous year.

Is there a fundamental bargaining power imbalance between news media businesses and the giant tech platforms, Google and Facebook that will affect consumers and jobs?

Melbourne-based small cap Antisense Therapeutics (ANP) aims to develop antisense drugs for under-researched diseases where there is a clear need for better treatments.

Looking for new inspiration this weekend? Here are some entertainment suggestions from the Switzer team.

Our Switzer Report webinar on July 3 saw Peter Switzer, Paul Rickard and finance journalist Tony Featherstone overview the stock market during the month of June and highlight 2 key investing resolutions for the new financial year.

The Eden-Monaro by-election is tomorrow, July 4. How has COVID-19 changed Australia’s political landscape?

Young Australian women under 30 say they wouldn’t invest in Rio Tinto after they blew up a 46,000-year-old Aboriginal heritage site. How seriously does this threaten the future of Australian blue-chips?

Looking for new inspiration in isolation this weekend? Here are some entertainment suggestions from the Switzer team.